GGrantIndex
← Leaderboards

Mark A Aronica

Vanderbilt University

$8,144,113
Attributed
$20,934,948
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4M · FY200623
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$20,934,948 · 6

By mechanism

U01$13,856,738 · 1
P01$4,646,580 · 3
R01$1,861,390 · 1
K08$570,240 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Asthma

Research focus

AsthmaInflammationProgramsLungCellsSeverity Of IllnessCytokineAllergensEpithelial CellsInflammatoryAirway EpitheliumLeukocytesMediator Of Activation ProteinProductionExtracellular MatrixPlayAirway HyperresponsivenessHyaluronanChronicAsthmatic AirwayResearch PersonnelAntigensStructureAirway Inflammation

Grant awards (33)

Immunometabolic phenotypes in adult severe asthma and disease progression$3,233,979
U01 · FY2023 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$216,239
U01 · FY2023 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,322,614
U01 · FY2022 · HL
Rapid saliva antigen test for SARS-CoV-2 detection$434,002
U01 · FY2022 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$235,989
U01 · FY2022 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,058,207
U01 · FY2021 · HL
Immunometabolic phenotypes in adult severe asthma and disease progression$3,355,708
U01 · FY2020 · HL
Mechanisms and Consequences of Hyaluronan Production in Asthma$327,942
P01 · FY2019 · HL · contact PI
Mechanisms and Consequences of Hyaluronan Production in Asthma$323,187
P01 · FY2018 · HL · contact PI
Mechanisms and Consequences of Hyaluronan Production in Asthma$327,942
P01 · FY2017 · HL · contact PI
Mechanisms and Consequences of Hyaluronan Production in Asthma$327,941
P01 · FY2016 · HL · contact PI
Targeting pathological hyaluronan matrices$409,272
P01 · FY2015 · HL · contact PI
Mechanisms and Consequences of Hyaluronan Production in Asthma$328,106
P01 · FY2015 · HL · contact PI
Animal Model Core$193,555
P01 · FY2015 · HL · contact PI
Targeting pathological hyaluronan matrices$407,600
P01 · FY2014 · HL · contact PI
Animal Model Core$191,886
P01 · FY2014 · HL · contact PI
Targeting pathological hyaluronan matrices$394,401
P01 · FY2013 · HL · contact PI
Animal Model Core$189,038
P01 · FY2013 · HL · contact PI
Targeting pathological hyaluronan matrices$414,285
P01 · FY2012 · HL · contact PI
Animal Model Core$198,570
P01 · FY2012 · HL · contact PI
Targeting pathological hyaluronan matrices$414,285
P01 · FY2011 · HL · contact PI
Animal Model Core$198,570
P01 · FY2011 · HL · contact PI
Extracellular Matrix Synthesis and Turnover in Asthma$364,245
R01 · FY2010 · AI · contact PI
Extracellular Matrix Synthesis and Turnover in Asthma$367,923
R01 · FY2009 · AI · contact PI
Extracellular Matrix Synthesis and Turnover in Asthma$367,923
R01 · FY2008 · AI · contact PI
Extracellular Matrix Synthesis and Turnover in Asthma$375,049
R01 · FY2007 · AI · contact PI
Extracellular Matrix Synthesis and Turnover in Asthma$386,250
R01 · FY2006 · AI · contact PI
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$114,048
K08 · FY2004 · HL
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$114,048
K08 · FY2003 · HL
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$114,048
K08 · FY2002 · HL
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$95,000
K08 · FY2001 · HL
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$19,048
K08 · FY2001 · HL
SIGNALING ALLERGIC LUNG DISEASE:NF-KB &T HELPER SUBSETS$114,048
K08 · FY2000 · HL